The committee concluded that UroLift is clinically effective, with sustained relief of lower urinary tract symptoms up to 5 years after treatment. It is implanted using a minimally invasive procedure.
More than 50% of men over the age of 50 suffer from benign prostatic hyperplasia, also known as an enlarged prostate. While BPH is common for older men, causing the frequent urge to urinate — ...
Dr. Irina Jaeger, director of urology at University Hospitals Richmond Medical Center, is making UroLift treatment for benign prostatic hypertrophy, or BPH, available in the area for the first time.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback